A world-first biodegradable vaccine to protect livestock from foot and mouth disease (FMD) has been developed through an Australian-led project.
Meat & Livestock Australia (MLA) Managing Director Michael Crowley said while it was hoped a FMD vaccine would never be needed, the research, the results of a partnership between MLA, Tiba Biotech and the NSW Government, represented a proactive approach to managing biosecurity risk.
Mr Crowley said while Australia remained FMD free, modelling from Australian Bureau of Agricultural and Resource Economics and Sciences (ABARES) estimated an FMD incursion could cost the Australian economy up to $80 billion.
He said an incursion would have a catastrophic impact on trade, animal welfare and farm productivity.
“FMD is present in countries near to Australia and is front of mind for industry in terms of potential biosecurity risks.
“Vaccination may not necessarily be required in the event of a disease incursion, but this research demonstrates that the Australian industry is proactive and prepared.”
Mr Crowley said researchers found the new vaccine demonstrated strong, effective immune response and safety in preliminary trials in Germany.
He said vaccinated cattle did not contract FMD when exposed to the disease and they did not shed the virus.
“Following these trials, the vaccine must now undergo a rigorous evaluation process with the Australian Pesticides and Veterinary Medicines Authority (APVMA) before approval for use on livestock.”
